Register Login

ORUKA THERAPEUTICS, INC. (ORKA)

Goncalves Joana 🟡 adjusted position in 7.0K shares (2 derivative) of Oruka Therapeutics, Inc. (ORKA) at $112.56 Transaction Date: Aug 17, 2026 | Filing ID: 000079

Full text
Register to leave comments
  • News bot Aug. 17, 2026, 10:10 p.m.

    🔍 Goncalves Joana (Executive)

    Company: Oruka Therapeutics, Inc. (ORKA)

    Report Date: 2026-08-17

    Transaction Summary:

    • Total transactions: 8
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 7,000
    • Total shares sold: 14,000

    Detailed Transactions and Holdings:

    • Acquired 3,500 shares of Common Stock at $6.84 per share (Direct)
      Date: 2026-08-17 | Code: M | equity_swap_involved: 0 | shares_owned_after: 36,218.00 | transaction_form_type: 4
    • Acquired 3,500 shares of Common Stock at $7.8 per share (Direct)
      Date: 2026-08-17 | Code: M | equity_swap_involved: 0 | shares_owned_after: 39,718.00 | transaction_form_type: 4
    • Sold 900 shares of Common Stock at $109.6522 per share (Direct)
      Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 38,818.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 300 shares of Common Stock at $110.5167 per share (Direct)
      Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 38,518.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 3,320 shares of Common Stock at $112.0138 per share (Direct)
      Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 35,198.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 2,480 shares of Common Stock at $112.5622 per share (Direct)
      Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 32,718.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 3,500 shares of Employee Stock Option (right to buy) at $6.84 per share (Derivative)
      Date: 2026-08-17 | Code: M | Expires: 2034-05-06 | equity_swap_involved: 0 | shares_owned_after: 197,063.00 | transaction_form_type: 4 | Footnotes: F6
    • Sold 3,500 shares of Employee Warrant (right to buy) at $7.8 per share (Derivative)
      Date: 2026-08-17 | Code: M | Expires: 2034-07-14 | equity_swap_involved: 0 | shares_owned_after: 168,492.00 | transaction_form_type: 4 | Footnotes: F7

    Footnotes:

    • F1: These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.05 to $110.04, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4.
    • F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.27 to $111.00, inclusive.
    • F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.34 to $112.33, inclusive.
    • F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.34 to $112.86, inclusive.
    • F6: The option vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025.
    • F7: The warrant vests as to 1/4 of the underlying shares on April 18, 2025 and as to 1/48 of the underlying shares monthly from April 18, 2025.

Search

News categories